☆ 4.7 Letter

Pseudoparticle Neutralization Assay for Detecting Ebola-Neutralizing Antibodies in Biosafety Level 2 Settings

CLINICAL CHEMISTRY (2015)

Journal

CLINICAL CHEMISTRY

Volume 61, Issue 6, Pages 885-886

Publisher

AMER ASSOC CLINICAL CHEMISTRY

DOI: 10.1373/clinchem.2015.238204

Keywords

-

Categories

Medical Laboratory Technology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern

Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, Vic Arendt, Therese Staub, Paul CON VINCE Consortium, Judith M. CoVaLux Consortium, Rejko Kruger, Guy Fagherazzi, Paul Wilmes, Judith M. Hubschen, Markus Ollert, Danielle Perez-Bercoff, Carole Seguin-Devaux

Summary: A new variant-adapted surrogate virus neutralization test (sVNT) was established, allowing for the efficient prediction of immune protection against different variants of concern.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Immunology

Comparison of Four SARS-CoV-2 Neutralization Assays

Lydia Riepler, Annika Roessler, Albert Falch, Andre Volland, Wegene Borena, Dorothee von Laer, Janine Kimpel

Summary: Neutralizing antibodies are crucial for protection against viruses like SARS-CoV-2. This study compared four different assays for detecting these antibodies and found that they were all robust and yielded comparable results, indicating their reliability.

VACCINES (2021)

Add to Collection

Article Infectious Diseases

Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS-CoV-2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients

Achala Kamaladasa, Banuri Gunasekara, Chandima Jeewandara, Deshni Jayathilaka, Ananda Wijewickrama, Dinuka Guruge, Ruwan Wijayamuni, T. K. Tan, Graham S. Ogg, Alain Townsend, Gathsaurie Neelika Malavige

Summary: This study compared two assays correlated with neutralizing antibodies in patients with different severity of illness and found that HAT is a more accurate method for detecting antibody levels. Using HAT as an indicator of neutralizing antibodies in resource-poor settings would be an ideal choice.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Microbiology

Development of a Rapid Live SARS-CoV-2 Neutralization Assay Based on a qPCR Readout

Sabine Lichtenegger, Sabine Saiger, Melina Hardt, Susanne Kulnik, Gabriel E. Wagner, Barbara Kleinhappl, Karoline Assig, Andrea Zauner, Michelle Ober, Janine Kimpel, Dorothee von Laer, Kurt Zatloukal, Ivo Steinmetz

Summary: Measurement of SARS-CoV-2 neutralizing antibodies is crucial for determining immunity against newly emerging variants. This study presents a faster live virus assay that detects neutralizing antibodies through early measurement of intracellular virus reduction by SARS-CoV-2 qRT-PCR. The assay showed high sensitivity and specificity, with a strong correlation to conventional virus neutralization assays, indicating its potential for rapidly determining immunity.

JOURNAL OF CLINICAL MICROBIOLOGY (2022)

Add to Collection

Article Virology

Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays

Jingyou Yu, Zhenfeng Li, Xuan He, Makda S. Gebre, Esther A. Bondzie, Huahua Wan, Catherine Jacob-Dolan, David R. Martinez, Joseph P. Nkolola, Ralph S. Baric, Dan H. Barouch

Summary: The study outlines a method to generate a highly infectious SARS-CoV-2 pseudovirus for evaluating humoral immunity, antibody therapeutics, and vaccines. The SDCT13-based pseudovirus neutralization assay exhibits key characteristics including linearity, limit of detection, and assay precision. This assay is adaptable for emerging SARS-CoV-2 variants and crucial for the development of vaccines and immune-based therapeutics.

JOURNAL OF VIROLOGY (2021)

Add to Collection

Article Immunology

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2

Filipe Colaco Mariz, Kerstin Putzker, Peter Sehr, Martin Mueller

Summary: The study presents an L2-oriented approach for measuring antibody-mediated neutralization of multiple HPV types using an optimized high-throughput pseudovirion-based neutralization assay (HT-PBNA) and a highly sensitive L2-peptide capture ELISA.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Microbiology

Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera

Kasopefoluwa Y. Oguntuyo, Christian S. Stevens, Chuan-Tien Hung, Satoshi Ikegame, Joshua A. Acklin, Shreyas S. Kowdle, Jillian C. Carmichael, Hsin-Ping Chiu, Kristopher D. Azarm, Griffin D. Haas, Fatima Amanat, Jeromine Klingler, Ian Baine, Suzanne Arinsburg, Juan C. Bandres, Mohammed N. A. Siddiquey, Robert M. Schilke, Matthew D. Woolard, Hongbo Zhang, Andrew J. Duty, Thomas A. Kraus, Thomas M. Moran, Domenico Tortorella, Jean K. Lim, Andrea Gamarnik, Catarina E. Hioe, Susan Zolla-Pazner, Stanimir S. Ivanov, Jeremy P. Kamil, Florian Krammer, Benhur Lee

Summary: The global COVID-19 pandemic has led to the development of a standardized virus neutralization assay using pseudotyped particles for efficient and accurate testing of neutralizing antibodies against SARS-CoV-2. The assay showed strong positive correlation with live-virus neutralizations in confirmed convalescent-patient sera and can be used for meaningful comparisons across diverse cohorts. This standardized assay is necessary for assessing the efficacy of various vaccines and antibody-based therapeutics.

MBIO (2021)

Add to Collection

Article Microbiology

Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference

Marianne Graninger, Claudia Maria Jani, Elisabeth Reuberger, Katja Prueger, Philipp Gaspar, David Niklas Springer, Christian Borsodi, Lisa Weidner, Susanne Rabady, Elisabeth Puchhammer-Stockl, Christof Jungbauer, Eva Hoeltl, Judith Helene Aberle, Karin Stiasny, Lukas Weseslindtner

Summary: This study provides adapted cutoff values for seven commercial immunoassays that correlate with specific titers of neutralizing antibodies. These immunoassays can be used as substitutes for live-virus neutralization tests in assessing protection against SARS-CoV-2.

MICROBIOLOGY SPECTRUM (2023)

Add to Collection

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi, Frauke Muecksch, Shlomo Finkin, Minami Tokuyama, Alice Cho, Mila Jankovic, Dennis Schaefer-Babajew, Thiago Y. Oliveira, Melissa Cipolla, Charlotte Viant, Christopher O. Barnes, Yaron Bram, Gaelle Breton, Thomas Hagglof, Pilar Mendoza, Arlene Hurley, Martina Turroja, Kristie Gordon, Katrina G. Millard, Victor Ramos, Fabian Schmidt, Yiska Weisblum, Divya Jha, Michael Tankelevich, Gustavo Martinez-Delgado, Jim Yee, Roshni Patel, Juan Dizon, Cecille Unson-O'Brien, Irina Shimeliovich, Davide F. Robbiani, Zhen Zhao, Anna Gazumyan, Robert E. Schwartz, Theodora Hatziioannou, Pamela J. Bjorkman, Saurabh Mehandru, Paul D. Bieniasz, Marina Caskey, Michel C. Nussenzweig

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans

Jackson S. Turner, Wooseob Kim, Elizaveta Kalaidina, Charles W. Goss, Adriana M. Rauseo, Aaron J. Schmitz, Lena Hansen, Alem Haile, Michael K. Klebert, Iskra Pusic, Jane A. O'Halloran, Rachel M. Presti, Ali H. Ellebedy

Summary: The study found that individuals who had recovered from mild SARS-CoV-2 infections showed rapid decline of serum anti-SARS-CoV-2 spike protein antibodies in the first 4 months after infection, followed by a more gradual decrease over the following 7 months but remaining detectable at least 11 months after infection. This suggests that mild infection with SARS-CoV-2 can induce robust antigen-specific, long-lived humoral immune memory in humans.

NATURE (2021)

Add to Collection

Article Biochemical Research Methods

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2

Jun-Gyu Park, Fatai S. Oladunni, Kevin Chiem, Chengjin Ye, Michael Pipenbrink, Thomas Moran, Mark R. Walter, James Kobie, Luis Martinez-Sobrido

Summary: The emergence of SARS-CoV-2 has caused a global pandemic with no approved vaccines or antivirals, putting pressure on the scientific community to develop effective treatments.

JOURNAL OF VIROLOGICAL METHODS (2021)

Add to Collection

Article Immunology

Prolonged evolution of the human B cell response to SARS-CoV-2 infection

Mrunal Sakharkar, C. Garrett Rappazzo, Wendy F. Wieland-Alter, Ching-Lin Hsieh, Daniel Wrapp, Emma S. Esterman, Chengzi Kaku, Anna Z. Wec, James C. Geoghegan, Jason S. McLellan, Ruth Connor, Peter F. Wright, Laura M. Walker

Summary: The study on the kinetics and evolution of the human B cell response to SARS-CoV-2 infection revealed that serum neutralizing antibody responses declined rapidly, while spike-specific IgG(+) memory B cells remained stable or increased over time. The research also showed evidence for prolonged antibody affinity maturation and the impact of mutations in the S protein on the neutralizing antibody response.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Virology

Rhinoviruses A and C elicit long-lasting antibody responses with limited cross-neutralization

Yury A. Bochkov, Mark Devries, Kaitlin Tetreault, Ronald Gangnon, Sujin Lee, Leonard B. Bacharier, William W. Busse, Carlos A. Camargo, Timothy Choi, Robyn Cohen, Ramyani De, Gregory P. DeMuri, Anne M. Fitzpatrick, Peter J. Gergen, Kristine Grindle, Rebecca Gruchalla, Tina Hartert, Kohei Hasegawa, Gurjit K. Khurana Hershey, Patrick Holt, Kiara Homil, Tuomas Jartti, Meyer Kattan, Carolyn Kercsmar, Haejin Kim, Ingrid A. Laing, Peter N. Le Souef, Andrew H. Liu, David T. Mauger, Tressa Pappas, Shilpa J. Patel, Wanda Phipatanakul, Jacqueline Pongracic, Christine Seroogy, Peter D. Sly, Christopher Tisler, Ellen R. Wald, Robert Wood, Robert F. Lemanske, Daniel J. Jackson, James E. Gern

Summary: This study examined cross-neutralization reactions and antibody duration of rhinovirus type A (RV-A) and type C (RV-C). The results showed limited cross-neutralization reactions between the two types, which are limited to genetically similar strains. However, the duration of antibody response during childhood is similar for both types.

JOURNAL OF MEDICAL VIROLOGY (2023)

Add to Collection

Review Immunology

Areas of Uncertainty in SARS-CoV-2 Vaccination for Cancer Patients

Anastasios Dimou

Summary: Early in the COVID-19 pandemic, it was recognized that infection with SARS-CoV-2 is associated with increased morbidity and mortality in patients with cancer. Therefore, preventive vaccination in cancer survivors is expected to be particularly impactful. However, the heterogeneity in how a neoplastic disease diagnosis and treatment interferes with immunity poses challenges in vaccination. This review critically appraises the available literature on the effectiveness of COVID-19 vaccines among cancer patients to inform future immunization programs and minimize treatment deviations.

VACCINES (2022)

Add to Collection

Review Immunology

Development of screening assays for use of broadly neutralizing antibodies in people with HIV

Rebecca M. Lynch, Katharine J. Bar

Summary: Treatment with combinations of complementary broadly neutralizing antibodies (bnAbs) has shown promise in maintaining virus suppression in some participants, but resistance to bnAbs remains a critical barrier. The development of a screening assay to guide bnAb selection is necessary. Current methods include outgrowth assays and sequence-based approaches, but there is a need for more research on in vitro neutralization assays and other measures of antibody functions.

CURRENT OPINION IN HIV AND AIDS (2023)

Add to Collection

Article Nanoscience & Nanotechnology

Transparent Anti-SARS-CoV-2 and Antibacterial Silver Oxide Coatings

Mohsen Hosseini, Alex W. H. Chin, Myra D. Williams, Saeed Behzadinasab, Joseph O. Falkinham, Leo L. M. Poon, William A. Ducker

Summary: Transparent antimicrobial coatings can reduce disease transmission while maintaining surface aesthetics and functionality. Researchers fabricated a coating with silver oxide particles, which showed a significant reduction in SARS-CoV-2 and other common bacteria. These transparent antimicrobial coatings are expected to be widely used on communal touch-screens.

ACS APPLIED MATERIALS & INTERFACES (2022)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Exploring the landscape of immune responses to influenza infection and vaccination

Sophie A. Valkenburg, Leo L. M. Poon

Summary: The antibody landscape after H3N2 vaccination is influenced by recent infections, and studying immune dynamics can help inform influenza vaccination strategies.

NATURE MEDICINE (2022)

Add to Collection

Article Cell & Tissue Engineering

A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4

Zhangjing Ma, Xisheng Li, Rebecca L. Y. Fan, Kevin Y. Yang, Calvin S. H. Ng, Rainbow W. H. Lau, Randolph H. L. Wong, Kevin K. Ng, Chi Chiu Wang, Peng Ye, Zelong Fu, Alex W. H. Chin, M. Y. Alison Lai, Yu Huang, Xiao Yu Tian, Leo L. M. Poon, Kathy O. Lui

Summary: The direct mechanism of SARS-CoV-2-induced endotheliitis is still unclear. This study found that human endothelial cells (ECs) have low expression of surface ACE2 and lower intracellular ACE2 compared to non-ECs in the lungs. Ectopically expressing ACE2 in hESC-ECs showed that ACE2-deficient ECs were resistant to infection but more activated than ACE2-expressing ECs. The virus induced endothelial activation by increasing monocyte adhesion, NO production, and phosphorylation of p38 MAPK, NF-kappa B, and eNOS in both ACE2-deficient and -expressing ECs. ACE2-deficient ECs responded to SARS-CoV-2 through TLR4, and its antagonist inhibited p38 MAPK/NF-kappa B/IL-1 beta activation. Single-cell RNA-seq analyses confirmed activation of the TLR4/MAPK14/RELA/IL-1 beta axis in circulating ECs of COVID-19 patients. Circulating ECs could serve as biomarkers for endotheliitis. These findings support a direct role of SARS-CoV-2 in mediating endothelial inflammation in an ACE2-dependent or -independent manner.

STEM CELL REPORTS (2022)

Add to Collection

Article Engineering, Environmental

Evaluation of RT-qPCR Primer-Probe Sets to Inform Public Health Interventions Based on COVID-19 Sewage Tests

Xiaoqing Xu, Yu Deng, Xiawan Zheng, Shuxian Li, Jiahui Ding, Yu Yang, Hei Yin On, Rong Yang, Ho-Kwong Chui, Chung In Yau, Hein Min Tun, Alex W. H. Chin, Leo L. M. Poon, Malik Peiris, Gabriel M. Leung, Tong Zhang

Summary: Sewage surveillance is a valuable supplementary tool for COVID-19 control, and the interpretation of sewage data is crucial. This study compared the performance of seven commonly used primer-probe sets in RT-qPCR and evaluated their usefulness in a sewage surveillance program in Hong Kong. The results showed that the N1 primer-probe set was the best in detecting signals from new cases and convalescent patients in the community.

ENVIRONMENTAL SCIENCE & TECHNOLOGY (2022)

Add to Collection

Editorial Material Infectious Diseases

Universal influenza vaccines are futile when benchmarked against seasonal influenza vaccines

Sophie A. Valkenburg, Leo L. M. Poon

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Environmental Sciences

Comparison of virus concentration methods and RNA extraction methods for SARS-CoV-2 wastewater surveillance

Xiawan Zheng, Yu Deng, Xiaoqing Xu, Shuxian Li, Yulin Zhang, Jiahui Ding, Hei Yin On, Jimmy C. C. Lai, Chung In Yau, Alex W. H. Chin, Leo L. M. Poon, Hein M. Tun, Tong Zhang

Summary: Wastewater surveillance is a promising tool for monitoring the spread of COVID-19, and this study evaluated different virus concentration methods for the detection of SARS-CoV-2 in wastewater. Ultracentrifugation was found to be the most effective method, and lysis-buffer-based extraction method resulted in higher viral recovery efficiencies.

SCIENCE OF THE TOTAL ENVIRONMENT (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Effect of Surface Porosity on SARS-CoV-2 Fomite Infectivity

Mohsen Hosseini, Leo L. M. Poon, Alex W. H. Chin, William A. Ducker

Summary: By comparing porous and nonporous solids with similar chemistry, the study reveals that porosity and permeability play important roles in the infectivity of SARS-CoV-2. Access to porosity decreases infectivity, and viral DNA may become trapped in the pores. Permeability and drying time also affect the infectivity.

ACS OMEGA (2022)

Add to Collection

Article Infectious Diseases

Development of multiplex RT-ddPCR assays for detection of SARS-CoV-2 and other common respiratory virus infections

Nathaniel K. C. Leong, Haogao Gu, Daisy Y. M. Ng, Lydia D. J. Chang, Pavithra Krishnan, Samuel S. M. Cheng, Malik Peiris, Leo L. M. Poon

Summary: Multiplex RT-ddPCR assays were developed and validated in COVID-19 cases to detect different respiratory viruses, showing their usefulness in screening for co-infections.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2023)

Add to Collection

Article Virology

Heterosubtypic immune pressure accelerates emergence of influenza A virus escape phenotypes in mice

Julie T. S. Chu, Haogao Gu, Wanying Sun, Rebecca L. Y. Fan, John M. Nicholls, Sophie A. Valkenburg, Leo L. M. Poon

Summary: Rapid antigenic evolution of influenza A virus undermines protection from seasonal vaccines and selects for immune escape mutants. We developed an in vivo mouse model to study viral adaptation and used next generation sequencing to evaluate viral evolution in the context of broad immunity. Heterosubtypic immune pressure increased the occurrence of genome-wide mutations, resulting in the manifestation of highly virulent phenotypes that ablated vaccine mediated protection. Escape variants with high frequency mutations were found in polymerase encoding segments, suggesting the polygenic changes may contribute to the formation of these variants.

VIRUS RESEARCH (2023)

Add to Collection

Editorial Material Microbiology

Coronavirus research: knowledge gaps and research priorities

Stanley Perlman, Malik Peiris

Summary: Decades of research on coronaviruses and studying SARS-CoV-2 during the COVID-19 pandemic have provided a great deal of knowledge, but there are still many unanswered questions and areas that need further research.

NATURE REVIEWS MICROBIOLOGY (2023)

Add to Collection

Correction Multidisciplinary Sciences

Reconstructing antibody dynamics to estimate the risk of influenza virus infection (vol 13, 1557, 2022)

Tim K. Tsang, Ranawaka A. P. M. Perera, Vicky J. Fang, Jessica Y. Wong, Eunice Y. Shiu, Hau Chi So, Dennis K. M. Ip, J. S. Malik Peiris, Gabriel M. Leung, Benjamin J. Cowling, Simon Cauchemez

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Multidisciplinary Sciences

Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals

Haogao Gu, Ahmed Abdul Quadeer, Pavithra Krishnan, Daisy Y. M. Ng, Lydia D. J. Chang, Gigi Y. Z. Liu, Samuel M. S. Cheng, Tommy T. Y. Lam, Malik Peiris, Matthew R. McKay, Leo L. M. Poon

Summary: Limited data is available on the genetic diversity of SARS-CoV-2 within hosts and its relationship with vaccination. The authors found that variant of Concern (VOC) samples have more sequence variations than non-VOC samples, and breakthrough infections in vaccinated individuals do not increase non-silent mutations. The study highlights the importance of understanding within-host diversity and the impact of vaccination on viral evolution.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Biotechnology & Applied Microbiology

Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseases

Michael Kwan Leung Yu, Sophelia Hoi Shan Chan, Samuel Cheng, Daniel Leung, Sau Man Chan, Amy Suen Ka Yan, Wilfred Hing Sang Wong, Malik Peiris, Yu Lung Lau, Jaime S. Rosa Duque

Summary: Hesitancy toward COVID-19 vaccination is common for patients with neuromuscular diseases due to the lack of safety and efficacy data in this high-risk population. This study examined the factors associated with vaccine hesitancy and evaluated the reactogenicity and immunogenicity of BNT162b2 and CoronaVac vaccines in patients with neuromuscular diseases. The results showed that both vaccines were safe and effective for these patients.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2023)

Add to Collection

Letter Immunology

Serological evidence of SARS-CoV-2 infection in dromedary camels and domestic bovids in Oman

Ihab El Masry, Salim Al Makhladi, Mohsin Al Abdwany, Afrah Al Subhi, Hatim Eltahir, Samuel Cheng, Malik Peiris, Emma Gardner, Sophie Von Dobschuetz, Baba Soumare, Madhur Dhingra, Keith Sumption, Markos Tibbo

Summary: SARS-CoV-2 infection in livestock species in Oman was investigated, and serological evidence of infection in cattle, sheep, goats, and dromedary camel was provided. Integrated data analysis of epidemiologically linked human and animal cases should be conducted to understand the extent of SARS-CoV-2 infection in animals and associated risks.

EMERGING MICROBES & INFECTIONS (2023)

Add to Collection

Article Immunology

Impact of host genetic polymorphisms on response to inactivated influenza vaccine in children

Tim K. Tsang, Can Wang, Nicole N. Y. Tsang, Vicky J. J. Fang, Ranawaka A. P. M. Perera, J. S. Malik Peiris, Gabriel M. Leung, Benjamin J. Cowling, Dennis K. M. Ip

Summary: In randomized controlled trials, the relationship between vaccine response and host single nucleotide polymorphisms (SNPs) in 23 candidate genes was explored in 550 children who received trivalent-inactivated influenza vaccine, with adjustment for multiple testing. The GT genotype in TLR7-1817G/T (rs5741880) was associated with lower odds (OR: 0.22, 95% CI: 0.09, 0.53) of having post-vaccination hemagglutination-inhibiting (HAI) titers ≥ 40, compared to the GG and TT genotypes. Similarly, the GT genotype in TLR8-129G/C (rs3764879) was associated with lower odds (OR: 0.47; 95% CI: 0.28, 0.80) of having post-vaccination HAI titers ≥ 40, compared to the GG and AA genotypes. These findings may contribute to the development of more effective vaccines.

NPJ VACCINES (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.